CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029
... to reach USD 2.2 billion by 2029 from an estimated USD 1.5 billion in 2024, at a CAGR of 8.1% during the forecast period. The growth of this market can be attributed to the research ... Read More
-
Neuromodulation Devices Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Internal and External), Application [Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS)], Biomaterial (Metallic, Polymeric, and Ceramic), and End User (Hospitals, Clinics, and Home Healthcare)
... Electrical Stimulation (GES), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS)], Biomaterial (Metallic, Polymeric, and Ceramic), and End User (Hospitals, Clinics, and Home Healthcare) According to our latest study on Neuromodulation Devices Market Forecast ... Read More
-
Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Research Report 2024
... break down and die. The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to ... Read More
-
Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Glioblastoma Multiforme (GBM). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Global Transdermal Drug Delivery Systems Market Size study & Forecast, by Technology (Electroporation, Radio Frequency, Iontophoresis, Microporation , Thermal, Mechanical arrays, Ultrasound, Others) by Application (CNS, Pain Management, Cardiovascular, Hormone, Immunological, Metabolic, Gastrointestinal, Infection, Cancer, Others) and Regional Analysis, 2023-2030
... Others) and Regional Analysis, 2023-2030 Global Transdermal Drug Delivery Systems Market is valued approximately at USD 59.16 billion in 2022 and is anticipated to grow with a growth rate of more than 11.90% over the ... Read More
-
Global Olanzapine Market Size study & Forecast, by Application (Schizophrenia, Bipolar Disorder, Others), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Drug stores and Retail Pharmacies, Online Providers) and Regional Analysis, 2023-2030
... Global Olanzapine Market is valued at approximately USD 1.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.3% during the forecast period 2023-2030. Olanzapine is a medication ... Read More
-
Global Brain Monitoring Market Size Study & Forecast, by Product Type (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Functional Magnetic Resonance Imaging, Other Product Types), by Application (Parkinson's Disease, Traumatic Brain Injury, Epilepsy, Other Applications), by End User (Hospitals, Diagnostic Centers), and Regional Analysis, 2023-2030
... (Hospitals, Diagnostic Centers), and Regional Analysis, 2023-2030 Global Brain Monitoring Market is valued at approximately USD 6.01 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.35% during ... Read More
-
Global Alzheimer's Disease Diagnostic Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Alzheimer's Disease Diagnostic is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential ... Read More
-
Brain Monitoring Market Size - By Product Type (Device [CT, MRI, EMG, TCD], Accessories [Electrode]), Modality (Fixed, Portable, Wearable), Procedure (Invasive, Non-invasive), Application, End-use (Hospital, Diagnostic Center) - Global Forecast, 2024 - 2032
... market size is anticipated to observe 6.4% CAGR from 2024 to 2032, driven by the increasing prevalence of neurological disorders, such as epilepsy, Alzheimer's disease, and Parkinson's disease. As per World Federation of Neurology, around ... Read More
-
Sweden Neurology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... The COVID-19 pandemic significantly impacted neurology care in Sweden during the early phase, which also impacted the usage of neurology devices. For instance, according to an article published by PubMed in January 2023, a study ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer's Disease, Parkinson's Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... Pacific, Latin America, Middle East and Africa). Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate ... Read More
-
2024 Global Pharmaceutical Preparations, Acting On The Central Nervous System And The Sense Organs, For Human Use Products Markets (2030 Outlook)
... Organs, For Human Use Products Markets (2030 Outlook) report features market size data globally, regionally and for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a ... Read More
-
DTx in Medical - Thematic Research
... condition. DTx can be prescribed on their own, or together with other therapies or devices to optimize health outcomes. The majority of DTx are designed for chronic conditions, respiratory conditions, and mental health or neurological ... Read More
-
Japan Herbal Tea Market, By Raw Material (Black Tea, Green Tea, Yellow Tea), By Type (Cinnamon, Dandelion, Chamomile, Ginger, Turmeric, Blends), By Product Type (Syrups, Premixes, Powdered Ready to Drink, Liquid Ready to Drink), By Packaging Type (Loose Tea, Paper Pouches, Tea Bags, Carton Packs, Can Packaging), By Function (Cognitive Health, Gut & Digestive Health, Multifunctional), By Distributional Channel (Store Based, Non-Store Based), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Packaging Type (Loose Tea, Paper Pouches, Tea Bags, Carton Packs, Can Packaging), By Function (Cognitive Health, Gut & Digestive Health, Multifunctional), By Distributional Channel (Store Based, Non-Store Based), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 ... Read More
-
Post Traumatic Stress Disorder (PTSD) Market Report and Forecast 2024-2032
... expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032 in the major markets, driven by increasing prevalence of post-traumatic stress disorder (PTSD), along with reducing stigma around mental health conditions. ... Read More
-
STXBP1 Encephalopathy
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
US Neurotechnology Market Research Report Forecast to 2040
... variety of purposes, including research, diagnosis & treatment, and enhancement. Furthermore, neurotechnologies can be invasive or non-invasive. Invasive neurotechnologies require the implantation of electrodes or other devices into the brain or nervous system. Non-invasive neurotechnologies ... Read More
-
Global Migraine Drugs Market Growth 2024-2030
... Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Migraine Drugs market. Migraine Drugs ... Read More
-
Angelman Syndrome
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic ... Read More
-
Encephalitis Market Report and Forecast 2024-2032
... encephalitis among people in the 7 major markets. The market size is anticipated to grow at a CAGR of 5.04% during the forecast period of 2024-2032 to achieve a value of USD 32.5 billion by ... Read More
-
Regenerative Medicine Market Assessment, By Component [Therapeutics, Tools, Banks, Services], By Product [Gene Therapy, Cell Therapy, Tissue Engineering, Organ Therapy, Small Molecules and Biologics], By Material [Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Others], By Application [Wound Care, Musculoskeletal, Ophthalmology, Oncology, Cardiovascular, Dermatology, Neurology, Others], By End-user [Hospitals, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Application [Wound Care, Musculoskeletal, Ophthalmology, Oncology, Cardiovascular, Dermatology, Neurology, Others], By End-user [Hospitals, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F Global regenerative medicine market size was valued at USD 24.91 billion in 2023, ... Read More
-
Japan Active Pharmaceutical Ingredient Market Assessment, By Synthesis [Biotech, Synthetic], By Potency [Traditional API, HPAPI], By Manufacturer [Captive APIs, Merchant APIs], By Type [Generic APIs, Innovative APIs], By Drug [Prescription Drugs, Over-the-counter Drugs], By Usage [Clinical, Research], By Application [Cardiovascular diseases, Oncology, Neurology, Orthopedic, Diabetes, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... [Clinical, Research], By Application [Cardiovascular diseases, Oncology, Neurology, Orthopedic, Diabetes, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan Active pharmaceutical ingredient market size was valued at USD 20.11 billion in FY2023, ... Read More
-
Magnetic Resonance Imaging Market Assessment, By Field Strength [Low, Medium, High, Ultra High], By Design [Open MRI, Traditional MRI, Wide Bore MRI], By Application [Cardiology, Oncology, Neurology, Musculoskeletal, Orthopedic, Gastroenterology, Others], By End-user [Hospitals, Diagnostic and Imaging Centers, Ambulatory Surgical Centers, Others], By Region, Opportunities and Forecast, 2017-2031F
... and Imaging Centers, Ambulatory Surgical Centers, Others], By Region, Opportunities and Forecast, 2017-2031F Global magnetic resonance imaging market size was valued at USD 7.4 billion in 2023, expected to reach USD 11.51 billion in 2031, ... Read More
-
Peripheral Interventions Market Forecasts to 2030 – Global Analysis By Product (Catheters, Sheath, Guide Wires, Atherectomy Devices, Embolic Devices, Stents, Inferior Vena Cava (IVC) Thrombectomy Devices, Plaque Modification Device, Hemodynamic Flow Alteration Devices and Other Products), Procedures (Oncology Procedures, Gastric, Neurology, Skin Procedures, Uteral, Renal, Hepatic and Other Procedures), Application, End User and By Geography
... Products), Procedures (Oncology Procedures, Gastric, Neurology, Skin Procedures, Uteral, Renal, Hepatic and Other Procedures), Application, End User and By Geography According to Stratistics MRC, the Global Peripheral Interventions Market is accounted for $8,952.2 million in ... Read More
Research Assistance
